These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9534199)

  • 1. Immunohistochemical analysis of thyroid adenomas with Hurthle cells.
    Kanthan R; Radhi JM
    Pathology; 1998 Feb; 30(1):4-6. PubMed ID: 9534199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
    Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors.
    Judkins AR; Roberts SA; Livolsi VA
    Hum Pathol; 1999 Nov; 30(11):1373-6. PubMed ID: 10571520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
    Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
    Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
    Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenocarcinoma: a histological and immunohistochemical study.
    Ko CJ; Cochran AJ; Eng W; Binder SW
    J Cutan Pathol; 2006 Nov; 33(11):726-30. PubMed ID: 17083691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurthle cell thyroid tumors. An immunohistochemical study.
    Johnson TL; Lloyd RV; Burney RE; Thompson NW
    Cancer; 1987 Jan; 59(1):107-12. PubMed ID: 3539304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid cell nests of the thyroid. A histologic and immunohistochemical study.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Hashimoto T; Nakamura S; Ishizaki T
    Am J Clin Pathol; 1994 Feb; 101(2):186-91. PubMed ID: 7509563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component.
    Stead RH; Qizilbash AH; Kontozoglou T; Daya AD; Riddell RH
    Hum Pathol; 1988 Jan; 19(1):32-40. PubMed ID: 2447009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hürthle cell neoplasms of the thyroid gland: an immunohistochemical study.
    Chetty R
    Histopathology; 1990 Oct; 17(4):368-70. PubMed ID: 2258175
    [No Abstract]   [Full Text] [Related]  

  • 17. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
    Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
    J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
    Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
    Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.